Abstract
Advances in drug stent-eluting technology, antiplatelet pharmacotherapy, and novel parenteral and oral anticoagulants have led to a constant evolution in periprocedural antithrombotic strategy. The following chapter outlines our cardiac catheterization laboratory’s current approach to antiplatelet and anticoagulation therapy in various clinical settings based on current guidelines, data, and expert opinion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gallagher AM, van Staa TP, Murray-Thomas T, et al. Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes. BMJ Open. 2014;4:e003839.
Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003;290:268.
Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864.
Lip GY. Implications of the CHA2DS2-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. Am J Med. 2011;124:111.
Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107.
National Collaborating Centre for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. London: Royal College of Physicians; 2006.
European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369.
O’shea JC, Madan M, Cantor WJ, et al. Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention. Am Heart J. 2000;149(2):S36–43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Patel, R., Rajamanickam, A., Kini, A. (2014). Antiplatelet and Antithrombotic Therapy in PCI. In: Kini, A., Sharma, S., Narula, J. (eds) Practical Manual of Interventional Cardiology. Springer, London. https://doi.org/10.1007/978-1-4471-6581-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6581-1_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6580-4
Online ISBN: 978-1-4471-6581-1
eBook Packages: MedicineMedicine (R0)